Article
Sudden death and cardiac arrest without phenotype: the utility of genetic testing.
Trends in cardiovascular medicine - 1 Apr 2017
Wijeyeratne Yanushi D, Behr Elijah R
Abstract excerpt
Approximately 4% of sudden cardiac deaths are unexplained [the sudden arrhythmic death syndrome (SADS)], and up to 6-10% of survivors of cardiac arrest do not have an identifiable cardiac abnormality after comprehensive clinical evaluation [idiopathic ventricular fibrillation (IVF)]. Genetic testing may be able to play a role in diagnostics and can be targeted to an underlying phenotype present in family members...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
